[HTML][HTML] Intestinal microbiota in inflammatory bowel disease: friend of foe?

F Fava, S Danese - World journal of gastroenterology: WJG, 2011 - ncbi.nlm.nih.gov
… Suggested mechanism of inflammatory bowel disease pathogenesis. Intestinal dysbiosis
in inflammatory bowel disease (IBD) consists of decreased prevalence of putative beneficial …

Friend or foe in inflammatory bowel disease pathogenesis: not all infections are equal

SC Shah - Gastroenterology, 2019 - gastrojournal.org
November 2019 Correspondence 1441 study and time period, with estimates as high as 95%
among some indigenous populations. 4 As an aside, although this study does not …

Th17-related cytokines in inflammatory bowel diseases: friends or foes?

I Monteleone, M Sarra, F Pallone… - Current molecular …, 2012 - ingentaconnect.com
diseases, including Crohn’s disease (CD) and ulcerative colitis (UC), the main forms of
inflammatory bowel diseases (… Th17 cells infiltrate massively the inflamed intestine of IBD patients …

[HTML][HTML] NLRP3 inflammasome in inflammatory bowel disease: friend or foe?

L Liu, X Li - Digestive diseases and sciences, 2017 - Springer
Inflammasomes are large multimeric protein complexes (Fig. 1) that actively regulate
cellular immunity and homeostasis through sensing and responding to either intracellular or …

NF-κB and the intestine: friend or foe?

T Karrasch, C Jobin - Inflammatory bowel diseases, 2008 - academic.oup.com
… cytokines, adhesion molecules, growth factors, and proliferative and survival genes is
associated with various inflammatory disorders including inflammatory bowel diseases (IBD). …

Contentious host–microbiota relationship in inflammatory bowel disease–can foes become friends again?

R Satokari - Scandinavian journal of gastroenterology, 2015 - Taylor & Francis
Inflammatory bowel diseases (IBDs) affect up to 3 million … colitis (UC) and Crohn’s disease
(CD). Epidemiological patterns suggest that IBD will emerge as a major worldwide disease in …

… of the IL‐18 system and other members of the IL‐1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?

BK Reuter, TT Pizarro - European journal of immunology, 2004 - Wiley Online Library
Crohn's disease and ulcerative colitis are examples of inflammatory bowel disease (IBD),
and are multifaceted chronic autoimmune disorders with unknown etiology; to date, there is no …

[HTML][HTML] Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?–a patient survey

C Barthel, S Wiegand, S Scharl, M Scharl, P Frei… - Nutrition journal, 2015 - Springer
Background Environmental factors are an integral component in the pathogenesis of
inflammatory bowel disease (IBD). There is an increasing interest in nutritive components. While …

[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in inflammatory bowel disease: friend or foe?

M Zou, QS Zeng, J Nie, JH Yang, ZY Luo… - Frontiers in …, 2021 - frontiersin.org
… ’s disease (CD) and ulcerative colitis (UC), exhibits a … , imbalance of gut microbiota, mucosal
immune disorder and … and development of inflammatory bowel disease. Ubiquitination …

[HTML][HTML] Intestinal inflammation and the diet: Is food friend or foe?

BW Megna, PR Carney, GD Kennedy - World journal of …, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic intestinal illness of autoimmune origin
affecting millions across the globe. The most common subtypes include ulcerative …